Cyclins and proliferation markers in early squamous cervical carcinoma.

[1]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[2]  R. Holm,et al.  Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. , 2003, Gynecologic oncology.

[3]  Isabelle Bedrosian,et al.  Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.

[4]  U. Jaeger,et al.  Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  P. V. van Diest,et al.  Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment , 2002, British Journal of Cancer.

[6]  C. Herrington,et al.  Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix. , 2001, Human pathology.

[7]  G. Bepler,et al.  MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Bryne,et al.  The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas , 2001, International Journal of Gynecologic Cancer.

[9]  K Stoeber,et al.  Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  M. Stanley,et al.  Biologic factors and response to radiotherapy in carcinoma of the cervix , 2001, International Journal of Gynecologic Cancer.

[11]  O. Nielsen,et al.  Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features. , 2001, American journal of clinical pathology.

[12]  S. Tsukagoshi,et al.  Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer. , 2000, Gynecologic oncology.

[13]  J. Gerdes,et al.  The Ki-67 protein: fascinating forms and an unknown function. , 2000, Experimental cell research.

[14]  Young Tae Kim,et al.  Expression of cyclin E and p27(KIP1) in cervical carcinoma , 2000 .

[15]  G. Williams,et al.  Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  M. Yamakawa,et al.  Expression of cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis , 1999, International journal of cancer.

[17]  R. Chetty,et al.  Cyclin E in human cancers , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  H. Skomedal,et al.  Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. , 1999, Gynecologic oncology.

[19]  B. Quade,et al.  In vivo cyclin E expression as a marker for early cervical neoplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  H. Moch,et al.  Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. , 1998, Anticancer research.

[21]  J. Torhorst,et al.  Expression of p150 in cervical neoplasia and its potential value in predicting survival , 1998, Cancer.

[22]  T. Nikaido,et al.  Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin‐dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix , 1998, Cancer.

[23]  C. Newlon.  Putting It All Together: Building a Prereplicative Complex , 1997, Cell.

[24]  J. W. Kim,et al.  Correlation between G1 Cyclins and HPV in the Uterine Cervix , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[25]  F. Landoni,et al.  Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer , 1997, The Lancet.

[26]  W. Zwerschke,et al.  Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. , 1996, Oncogene.

[27]  Ying-jv Lu,et al.  Prognostic factors of early stage cervical cancer treated by radical hysterectomy , 1995, Cancer.

[28]  C. Romanini,et al.  MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity. , 1995, Gynecologic oncology.

[29]  L. Bonetta,et al.  Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. , 1994, Oncogene.

[30]  R. Scully,et al.  Histological Typing of Female Genital Tract Tumours , 1994, World Health Organization International Histological Classification of Tumours.

[31]  James M. Roberts,et al.  A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.

[32]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[33]  K. Keyomarsi,et al.  Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. , 1992, The Journal of biological chemistry.

[34]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[35]  K. Gatter,et al.  Monoclonal antibody Ki‐67: its use in histopathology , 1990, Histopathology.

[36]  B. Sevin,et al.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[37]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[38]  T. Inoue,et al.  Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation , 1984, Cancer.

[39]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[40]  Yasuo Watanabe,et al.  Aberrant expression of cyclin A in laryngeal squamous cell carcinoma. , 2002, Anticancer research.

[41]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri. , 2001, Journal of epidemiology and biostatistics.

[42]  D. Ho,et al.  MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. , 2000, Gynecologic oncology.

[43]  K. Oka,et al.  MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[44]  H. Nakano,et al.  Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy , 1992, Cancer.